Last updated 2026-09-02
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$27.0M
total disclosed, rounds participated
Stages
Seed, Series A
About
Yishay Yovel is a Founding General Partner at Skinos Ventures, a new venture capital fund focused on cybersecurity investments. He previously served as Chief Marketing and Strategy Officer at Cato Networks, and held executive marketing roles at Imperva and Trusteer. Yovel is recognized for his role in the rise of the SASE category and has over 25 years of experience in marketing and product management in enterprise software companies.
Portfolio · 1
Q&A
- What is Yishay Yovel's primary role and firm?
- Yishay Yovel is a Founding General Partner at Skinos Ventures, an early-stage, cyber-focused VC fund.
- What is Skinos Ventures' investment focus?
- Skinos Ventures focuses on early-stage cyber companies at the intersection of cybersecurity and artificial intelligence.
- What investment stages does Skinos Ventures target?
- Skinos Ventures targets Seed and Series A investment stages.
- What is the typical check size for Skinos Ventures?
- Skinos Ventures typically invests a check size of $2,500,000.
- What is the total AUM for Skinos Ventures?
- Skinos Ventures has a total AUM of $26,000,000.
- Which fund has Skinos Ventures raised?
- Skinos Ventures raised Skinos Ventures Fund I in 2026, with a size of $26,000,000.
- Who is a key strategic advisor at Skinos Ventures?
- Shlomo Kramer serves as a Strategic Advisor.
- What is Yishay Yovel's background prior to Skinos Ventures?
- Yishay Yovel previously served as Chief Marketing and Strategy Officer at Cato Networks and held executive marketing roles at Imperva and Trusteer.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | skinos.vc/ |
|---|---|
| linkedin.com/in/yishayyovel/ |
Identifiers & details
| Founded | 2026-5 |
|---|
Radar intelligence
Web history (Wayback)
| Domain | skinos.vc |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|